When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
XERS - FDA OKs Xeris Pharma's glucagon for severe low blood sugar in diabetics
Xeris Pharmaceuticals Inc.
The FDA approves Xeris Pharmaceuticals' (XERS+0.9%) GVOKE (glucagon), a ready-to-use, room temperature-stable liquid glucagon for the treatment of severe hypoglycemia (low blood sugar) in diabetics at least two years old. It will be available in prefilled syringe and autoinjector (HypoPen) formats.
More news on: Xeris Pharmaceuticals, Inc., Healthcare stocks news, Stocks on the move,